galiximab in combination with rituximab

DRUG2 trials

Sponsors

Biogen

Conditions

Lymphoma, Non-Hodgkin's

Phase 3

A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)

TerminatedNCT00363636

BiogenLymphoma, Non-Hodgkin's

Start: 2006-09-30End: 2010-04-30Updated: 2015-10-02

Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)

TerminatedNCT00384150

BiogenLymphoma, Non-Hodgkin's

Start: 2007-11-30End: 2010-01-31Updated: 2015-11-26